Stay updated on Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The record history now shows the latest revision (v3.5.4) as the current version, replacing the earlier v3.5.3 entry.
    Difference
    0.1%
    Check dated 2026-05-15T06:26:46.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The page revision/version label was updated from v3.5.2 to v3.5.3, reflecting a site or interface version change rather than any update to the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T05:53:53.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:21:10.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added to the record history and Revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:10:52.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision history updated: added v3.4.3 and removed v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T23:27:10.000Z thumbnail image
  9. Check
    112 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history; deletions remove a government-funding notice and the older Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T12:14:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.